| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |